Real-world evidence on infection risks from multiple sclerosis treatments remains limited, with inconsistent findings ...

Herantis Pharma Plc ('Herantis'), a clinical-stage company developing disease-modifying therapies to stop Parkinson’s disease, releases today the Company’s 1H 2025 report. The full report is available ...

DelveInsight projects strong NMOSD market growth in the 7MM through 2032, fueled by disease-modifying therapies and key ...

Middle school teachers can guide students to analyze real-world data to gain a deep understanding of course content.

Metformin, rapamycin, and senolytics show multifaceted effects on aging biology that could transform how clinicians approach ...

Scientists have recently discovered an innovative approach to data storage by harnessing the natural capabilities of DNA.

Enable and configure Windows 11's Controlled Folder Access to add a layer of protection against ransomware targeting locally stored data.

The National Identity Management Commission (NIMC) has released important access guidelines for Nigerians using its self-service portal to modify their ...

Patient visits are now complete in the final cohort of Phase 1b trial, consisting of Parkinson’s disease patients receiving 300 mg doses of HER-096 or placebo twice weekly over a four-week ...